Ajanta is the pioneer in generic anti-malaria product of Artemether-Lumefantrine (immediate release and dispersible tablets) combination in Africa.
We were the 1st generic player pre-qualified by WHO Geneva for this product and hold leadership position in the segment. With focus on Africa’s hardest malaria hit countries we have been able to treat over 1 billion patients in about a decade. We are committed to bringing more of our medicines to more people, no matter where they are.
![](https://ajantapharma.com//images/businessareas_africa_institution_1.jpg)
![](https://ajantapharma.com//images/businessareas_africa_institution_2.jpg)
![](https://ajantapharma.com//images/businessareas_africa_institution_3.jpg)
![](https://ajantapharma.com//images/businessareas_africa_institution_4.jpg)
![](https://ajantapharma.com//images/businessareas_africa_institution_5.jpg)